Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494077 · ClinicalTrials.gov registry record
Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 32
- Enrollment target
NCT01494077 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 32 participants.
The verdict
NCT01494077 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this research project is to determine if pancreatic cyst fluid can be diluted and provide an accurate Carcinoembryonic Antigen (CEA) level. The investigators hypothesis is that pancreatic cyst fluid obtained by EUS-FNA can be diluted effectively and accurately for the measurement of CEA levels.
Interventions
- OTHER Laboratory processing for results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01494077
The ClinicalTrials.gov registry entry for NCT01494077 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laboratory processing for results is the first listed.
NCT01494077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01494077 about?
NCT01494077 is a clinical study titled "Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement". The purpose of this research project is to determine if pancreatic cyst fluid can be diluted and provide an accurate Carcinoembryonic Antigen (CEA) level. The investigators hypothesis is that pancreatic cyst fluid obtained by EUS-FNA can be diluted effectively and accurately for the measurement of C...
What is the current status of trial NCT01494077?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2011-04. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01494077?
The interventions under investigation include: Laboratory processing for results (OTHER).
Who is sponsoring clinical trial NCT01494077?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.